Decision Making in Neonatology : a Qualitative Study

This study aimed to describe and understand the decision making process in neonatology in situations of limiting of withdraw life sustaining treatments, by conducting interviews with physicians from one neonatology unit.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Premature Birth Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Obstetric Labor, Premature Pregnancy Complications Urogenital Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Physicians in charge of new born babies for whom a decision making regarding limiting or withdrawing treatments is emerging.
physicians' informed consent to participate to an interview
parents' informed consent to collect data concerning their new born.

Exclusion criteria

Not fluent French speaker

Treatment and study plan

semi-structured interviews

Other

individual semi-structured interviews

Primary outcomes

semi-structured interviews

Time frame: 3 months

qualitative data analysis - theorical saturation

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Registry information

Acronym: PRODA

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2014
First posted: Oct 27, 2017
Registry last updated: Nov 8, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed